Navigation Links
LX80 Series Precision Stages from Parker Hannifin Corporation

ProductsLX80 Series Precision Stages from Parker Hannifin Corporation
Company Parker Hannifin Corporation
Item LX80 Series Precision Stages
Price Inquire
Description The LX80L is an extension of Parkers MX80 family of positioners, offering longer travel while maintaining a compact cross-section. LX80L bolt hole patterns mimic the MX80 family, allowing users to directly mount MX80 units and all accessory brackets to build multi-axis systems.
  • Miniature linear motor stage with travel to 750 mm
  • Accelerations to 5 gs
  • Velocities to 3 m/s
  • Encoder resolution to 0.1 micron
  • Easy multi-axis mounting
  • Internal cable management
  • Cleanroom compatible
  • Ideal for larger work area gantry systems
Info Parker Hannifin CorporationParker Hannifin Corporation
242 Neck Road
Haverhill, MA 01835
Customer Service: (800) 343-4048
Fax Number: (978) 556-7510
Web Site: http://www.parker.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. LV Series Miniature Stepper Motors from Parker Hannifin Corporation
2. 7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
3. Agilent 1200 Series HPLC-Chip/MS System from Agilent Technologies
4. Staccato Custom Series from Caliper Life Sciences
5. Printer Paper for Model 680 Series Readers, 2 rolls from Bio-Rad
6. The Discovery Series PDQuest Version Upgrade from Bio-Rad
7. Agilent 1200 Series Nanoflow LC System for MS from Agilent Technologies
8. ProteinChip System, Series 4000 from Ciphergen
9. LS Series Microarray Laser Scanner from Tecan
10. Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
11. Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
(Date:7/31/2015)... , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... has filed provisional patent 62/198989 for ELECTRONIC ... highlights a method to advance crypto-currencies such as Bitcoin ... a common, uniform way to manage all payments.  ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
(Date:7/20/2015)... 20, 2015  Acuity Market Intelligence,s latest research ... of Commerce and Privacy" forecasts that between 2014 ... will be downloaded to smart mobile devices by ... market is projected to generate more than $67.9 ... seven-year forecast period.    "Biometrics is ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... at the University of Chicago finds evidence for a ... of loneliness: They create people in their surroundings to ... very efficient way to alleviate ones loneliness, but you ... so, said Nicholas Epley, Assistant Professor of Behavioral Science ...
... French . Researchers at the ... neurological basis of depression in male athletes with persisting ... of Archives of General Psychiatry, has important clinical implications ... cerebral concussion. Depression is one of a ...
... German . Genetically engineered products have become ... future, gene therapy should make it possible to introduce genes ... can address deficiencies to compensate for malfunctions in the body. ... must be introduced into host cells, which is not exactly ...
Cached Biology News:People not always needed to alleviate loneliness 2People not always needed to alleviate loneliness 3MNI researchers locate neurological basis of depression following sports concussion 2Cells get sprayed 2
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., ... of their 2nd generation cell therapy POD® design. The 2nd generation portfolio not ... represents a new POD® design. , “G-CON first offered our miniPOD CT ...
(Date:7/29/2015)... CHICAGO , July 29, 2015  AmnioChor Inc., ... cell technology, is very pleased to announce that the ... has agreed to invest in their seed round ... OmniBank placental tissue storage capabilities. AmnioChor,s ... placenta, and the human stem cells living within those ...
(Date:7/29/2015)... , July 29, 2015  Indivior PLC (LON: ... for naloxone nasal spray was accepted and received Priority ... for the treatment of opioid overdose. This naloxone nasal ... specially formulated for optimal absorption into the nasal mucosa. ... minimal training so individuals may be better equipped to ...
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3